Skip to main content
Livermore
Livermore
ZHEN

Commonwealth Equity Services, LLC

SEC CIK
0000312272
Latest filing
Jul 29, 2026

HRTX holding history

Heron Therapeutics, Inc. in every 13F filed by Commonwealth Equity Services, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

HRTX overviewAll 13F holders of HRTXFull Q2 2026 holdings

Shares (Q2 2026)
59,176
Value
$25.3K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of HRTX by Commonwealth Equity Services, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202659,176$25.3K<0.1%−550−0.9%ReducedHolders
Q1 202659,726$47.8K<0.1%+300+0.5%AddedHolders
Q4 202559,426$77.3K<0.1%−620−1.0%ReducedHolders
Q3 202560,046$76.0K<0.1%−12,074−16.7%ReducedHolders
Q2 202572,120$149.0K<0.1%+4,819+7.2%AddedHolders
Q1 202567,301$148.0K<0.1%−925−1.4%ReducedHolders
Q4 202468,226$104.0K<0.1%+4,550+7.1%AddedHolders
Q3 202463,676$127.0K<0.1%+6,925+12.2%AddedHolders
Q2 202456,751$199.0K<0.1%−281,775−83.2%ReducedHolders
Q1 2024338,526$938.0K<0.1%+10,122+3.1%AddedHolders
Q4 2023328,404$558.0K<0.1%+13,578+4.3%AddedHolders
Q3 2023314,826$324.0K<0.1%+16,467+5.5%AddedHolders
Q2 2023298,359$346.0K<0.1%+278,497+1,402.2%AddedHolders
Q1 202319,862$29.0K<0.1%−750−3.6%ReducedHolders
Q4 202220,612$51.0K<0.1%−525−2.5%ReducedHolders
Q3 202221,137$89.0K<0.1%+4,615+27.9%AddedHolders
Q2 202216,522$46.0K<0.1%+5,000+43.4%AddedHolders
Q1 202211,522$65.0K<0.1%−80−0.7%ReducedHolders
Q4 202111,602$105.0K<0.1%−19,458−62.6%ReducedHolders
Q3 202131,060$332.0K<0.1%−371−1.2%ReducedHolders
Q2 202131,431$487.0K<0.1%+516+1.7%AddedHolders
Q1 202130,915$501.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.